Neurocrine Biosciences (NBIX) Profit Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) profit margin from Jun 30, 2010 to Mar 31, 2026. The current Neurocrine Biosciences (NBIX) profit margin is 24.30%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Neurocrine Biosciences (NBIX)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 16.73% | +15.46% |
| 2024 | 14.49% | +9.51% |
| 2023 | 13.23% | +27.50% |
| 2022 | 10.38% | +31.29% |
| 2021 | 7.90% | -79.70% |
| 2020 | 38.94% | +729.48% |
| 2019 | 4.69% | -80.62% |
| 2019 | 24.22% | -13.35% |
| 2019 | 27.96% | -137.90% |
| 2019 | -73.77% | -1677.53% |
| 2018 | 4.68% | -86.02% |
| 2018 | 33.45% | -648.46% |
| 2018 | -6.10% | -89.63% |
| 2018 | -58.83% | -33.29% |
| 2017 | -88.19% | +381.95% |
| 2017 | -18.30% | -98.07% |
| 2017 | -946.06% | +0.58% |
| 2016 | -940.60% | +632.55% |
| 2016 | -128.40% | -71.46% |
| 2015 | -449.82% | +7373.11% |
| 2015 | -6.02% | -99.62% |
| 2013 | -1578.42% | +3.53% |
| 2013 | -1524.66% | -9.07% |
| 2013 | -1676.71% | +1.41% |
| 2013 | -1653.42% | -17567.79% |
| 2012 | 9.47% | -128.77% |
| 2012 | -32.91% | +595.63% |
| 2012 | -4.73% | -40.10% |
| 2012 | -7.90% | -116.27% |
| 2011 | 48.53% | -35.61% |
| 2011 | 75.38% | +362.93% |
| 2011 | 16.28% | -29.27% |
| 2011 | 23.02% | -196.77% |
| 2010 | -23.79% | -98.62% |
| 2009 | -1730.17% | N/A |
Comparison Neurocrine Biosciences (NBIX) profit margin with competitors
Neurocrine Biosciences (NBIX) profit margin is 24.30%.